Background-As maternal fever affects approximately 6-8% of early pregnancies, it is important to expand upon previous observations of an association between maternal fever and birth defects.
| INTRODUCTION
The possibility of a teratogenic effect of fever was first postulated by researchers conducting ecologic studies of influenza and birth defects (Janerich, 1971; MacMahon & Yen, 1971) . Stronger evidence of an association between maternal exposure to hyperthermia and an increased occurrence of birth defects was subsequently provided by animal studies (Cawdell-Smith, Upfold, Edwards, & Smith, 1992; Edwards, Shiota, Smith, & Walsh, 1995; Finnell, Moon, Abbott, Golden, & Chernoff, 1986) and epidemiologic studies of fever and neural tube defects (NTDs) (Kurppa, Holmberg, Kuosma, Aro, & Saxen, 1991; Li et al., 2007; Lynberg, Khoury, Lu, & Cocian, 1994; Medveczky, Puho', & Czeizel, 2004; Milunsky et al., 1992; Moretti, Benjamin, Fried, & Koren, 2005; Shaw, Todoroff, Velie, & Lammer, 1998; Shaw et al., 2002; Suarez, Felkner, & Hendricks, 2004; Yin et al., 2011; Zhang and Cai, 1993) . A recent systematic review by Dreier, Andersen, and Berg-Beckhoff (2014) noted that the literature supports an association between maternal fever and an increased risk of birth defects, with the strongest associations for NTDs, oral clefts and cardiac defects. However, the association with many other categories of birth defects has not been addressed and many of the existing studies do not distinguish between the effects of maternal fever and the illnesses that cause it.
Using data from the National Birth Defects Prevention Study (NBDPS), our objective was to determine whether maternal fever in response to a cold or flu during early pregnancy is a risk factor for any of 30 categories of noncardiac birth defects, independent of the underlying illness.
As maternal fever in early pregnancy affects approximately 6 to 8% of pregnant women in the United States (Dreier et al., 2014; Moretti et al., 2005) , continued research in this area may generate findings that can be used to provide evidence-based advice to a large number of pregnant women and their health care providers. Also, clarification of the specific categories of birth defects associated with maternal fever may provide insight into differences in the mechanisms of teratogenicity across categories of birth defects.
| MATERIALS AND METHODS
The NBDPS is a population-based, multistate, case-control study of risk factors for selected major structural malformations. Detailed study methods have been published previously (Rasmussen et al., 2003; Reefhuis et al., 2015) . Cases and controls had estimated dates of delivery between October 1, 1997 and December 31, 2011. Cases were ascertained by surveillance systems at ten sites (Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah). Controls were live born infants without birth defects, selected from birth certificates or birth hospital logs to be representative of the population from which the cases arose. This study was approved by the Institutional Review Boards of each study site and the Centers for Disease Control and Prevention.
Cases included live births, fetal deaths and pregnancy terminations. All cases were diagnosed by physical examination, imaging, autopsy, or pathology reports from surgical procedures. Case infants were aggregated across study sites and reviewed by clinical geneticists affiliated with the NBDPS according to established guidelines and classified as having isolated, multiple, or complex birth defects (Rasmussen et al., 2003) . Cases with isolated birth defects were defined as having either one major birth defect, two or more major birth defects affecting only one organ system, or one major birth defect with a sequence of related defects. Cases with multiple birth defects had two or more major unrelated defects in different organ systems. Birth defects that were known or strongly suspected to have been caused by single-gene disorders or chromosomal abnormalities were excluded from the NBDPS. Utah was unable to contribute cases of orofacial clefts in 2003, and cases of congenital cataracts were only contributed study-wide beginning January 1, 2000. For calculations involving these birth defects, we excluded information from controls for those locations and study periods during which cases were not available. Controls for analyses of hypospadias were restricted to male infants because all cases of hypospadias were male.
Maternal interviews were conducted using a standardized computer-assisted telephone interview, in either English or Spanish, between 6 weeks and 24 months from the estimated date of delivery. Participation rates were 67% for controls and 64% for cases. Interviews were completed within an average of 11 months from the estimated date of delivery for case mothers and 9 months for control mothers.
| EXPOSURE ASSESSMENT
A sequence of interview questions were used to obtain maternal histories of cold or flu before and during pregnancy. Mothers were asked whether they had "a cold or flu" during this time period. If they answered yes, they were asked to give the dates that the illness began and ended and whether they had a fever in response to it. If they could not provide exact dates they were allowed to report the month immediately before conception or during gestation that the cold or flu occurred. For each fever they were asked "what was the highest temperature recorded during your fever?" Mothers were also asked about fevers not related to cold or flu. However, in this analysis we focused exclusively on the effect of fevers in response to a cold or flu, which comprised 83 percent of all fevers reported.
We assessed illnesses due to cold and flu during the 3 month time period beginning 1 month (30 days) prior to conception and ending 2 months (60 days) after conception. We classified maternal exposures that occurred during this time period into one of three categories; (1) maternal report of cold or flu with fever, (2) maternal report of cold or flu without fever, (3) no maternal report of cold or flu (referent). Mothers who reported a cold or flu outside of the defined time period were considered unexposed and included in the referent group. We also assessed whether our results for exposure to cold or flu with fever during the critical period changed when we stratified maternal reports of fever into three groups according to the mother's report of the maximum reported temperature and compared the effect of these three exposure subgroups with the referent group of no fever.
| STATISTICAL ANALYSIS
We excluded mothers who were missing information on whether or not they had a cold or flu during the exposure window of interest or missing information on one or more of the covariates described below.
Using logistic regression, we calculated crude and adjusted ORs (cOR and aOR, respectively) for the association between maternal report of cold or flu with fever and maternal report of cold or flu without fever and 30 categories of NBDPS noncardiac birth defects, compared with the referent group which was comprised of mothers who gave no report of a cold or flu during the defined time period. As Botto et al. (2014) published results for the association between maternal fever and different categories of cardiac birth defects using the NBDPS database, we limited the current study to non-cardiac birth defects. We included only those categories of noncardiac birth defects for which there were at least three cases exposed to cold or flu with fever.
We controlled for the potential of confounding by maternal age (<18 years, 19-24 years, 25-29 years, 30-34 years, 35-39 years, and ≥40 years), maternal race and ethnicity (nonHispanic White, non-Hispanic Black, Hispanic, and other race or ethnicity), maternal level of educational attainment (less than high school [<9 years of completed education], some high school [9-11 years], high school graduate [12 years], some college [13-15 years], and college graduate [≥16 years]), any maternal smoking between 1 month before conception and 3 months after conception (yes, no), maternal prepregnancy body mass index (BMI; <18.5 kg/m 2 , 18.5-24.9 kg/m 2 , 25.0-29.9 kg/m 2 , and ≥30.0 kg/m 2 ), first live birth (yes, no), timing and frequency of maternal use of supplements containing folic acid (optimal intake daily from 1 month before conception to 1 month after conception), suboptimal intake (any intake during the same period), poor intake (intake beginning later than 1 month after conception or no intake), and study site (Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah).
We also undertook five sensitivity analyses to determine whether specific changes in the analysis would affect our results. For each of these, we implemented a single change and recalculated all aORs: (a) To confirm that the effects of fever did not extend to exposures that occurred later than 60 days of gestation, we calculated aORs for maternal reports of cold or flu with fever during the 3rd or 4th month of pregnancy (61-120 days after conception); (b) We calculated aORs excluding 17.5% of case mothers with infants with multiple or complex birth defects; (c) We calculated aORs excluding 7.0% of case and control mothers who reported a fever from an illness other than a cold or flu during the critical period from 1 month prior to conception to 2 months after conception (As we did not have information on the timing of fevers associated with urinary tract infection, in this step we excluded all fevers that were associated with a UTI, irrespective of their timing); (d) We calculated aORs excluding 2.0% of case and control mothers with pre-existing Type I or Type II diabetes mellitus; (e) As use of aspirin or ibuprofen during early pregnancy is associated with some categories of birth defects (Hernandez et al., 2012) we calculated aORs excluding 28.4% of case and control mothers who took these medications during the critical period from 1 month before conception to 2 months after conception. As a previous NBDPS analysis found no association between use of acetaminophen during early pregnancy and the birth defects that we studied, we did not run analyses excluding mothers who took acetaminophen during the critical period (Feldkamp, Meyer, Krikov, & Botto, 2010) .
| RESULTS
After excluding 9.4% of study participants that were missing information on whether or not they had a cold or flu during the exposure window of interest and 6.6% who were missing information on one or more of the covariates, 17,162 cases mothers and 10,127 control mothers remained in our analysis.
Case and control mothers were similar with respect to use of supplements containing folic acid (Table 1) . Case mothers were slightly more likely to be younger than 25 or older than 40 years of age, smokers, obese, having their first live birth or having attained less than a high school education. Case mothers were slightly less likely to be college graduates or of non-Hispanic Black race/ethnicity (Table 1) .
We assessed the percentage of mothers that reported a cold or flu during the exposure period, separately by the 30 cases groups and the control group (Table 2) . Among the controls, 6.5% (662/10,127) of mothers reported exposure to cold or flu with fever, and 12.7% (1282/10,127) reported exposure to cold or flu without fever (Table 2) . Among cases, the percent of mothers who reported exposure to cold or flu with fever ranged from 3.4% (3/89) for sacral agenesis to 18.0% (9/50) for colonic atresia/stenosis and the percent of mothers who reported exposure to cold or flu without fever ranged from 6.4% for bladder extrophy (4/62) to 16.1% for choanal atresia (23/143) ( Table 2) .
After adjustment for covariates, maternal cold or flu with fever during the exposure period was associated with statistically significant elevated odds ratios ranging from 1.23 to 3.68 for 8 of the 30 birth defects that we studied (anencephaly, spina bifida, encephalocele, cleft lip with or without cleft palate, colonic atresia/stenosis, bilateral renal agenesis/hypoplasia, limb reduction defects, and gastroschisis) ( Table 3 ). There were no statistically significant reduced risk aORs for maternal exposure to cold or flu with fever (Table 3) . For mothers who reported a cold or flu without fever during the exposure period, none of the aORs indicated an elevated or reduced risk that was statistically significant (Table 3) .
Among women who reported a cold or flu with fever during the critical period, 40% reported that the maximum temperature of fever was ≥101 degrees Fahrenheit (F), 21% reported it was <101 degrees F and 39% did not answer the question. The aORs associated with maternal reports of cold or flu with fever ≥101 were not substantially different from the aORs associated with maternal report of cold or flu with fever < 101 (not shown).
For the first sensitivity analysis, we observed no statistically significant elevated aORs between maternal reports of cold or flu with fever during the 3rd or 4th month of pregnancy (61-120 days) and major noncardiac birth defects (Table 4) . However, the aOR for duodenal atresia showed a statistically significant reduced risk (aOR = 0.35, 95% CI = 0.13, 0.94). (Table 4) The sensitivity analysis restricted to isolated birth defects (i.e., excluding the case mothers who had infants with multiple birth defects or complex birth defects) resulted in findings consistent with those observed in the main analyses in Table 3 (not shown), with the exception of glaucoma/anterior chamber defects, for which a statistically significant association was observed for maternal report of a cold or flu without fever (aOR = 1.78, 95% CI 1.12, 2.85).
The three additional sensitivity analyses resulted in findings very similar to those observed in Table 3 (not shown). In each of these three analyses, maternal report of cold or flu with fever during the critical gestational period was associated with statistically significant elevated aORs for the 8 birth defects described above with no additional significant findings.
| DISCUSSION
This study used data from the NBDPS to assess associations between (1) maternal exposure to a cold or flu with fever and (2) maternal exposure to cold or flu without fever and noncardiac birth defects. The large size of this population based database allowed us to study the association between these exposures and 30 noncardiac birth defects, including 20 birth defects for which this relationship had not yet been studied.
| Positive associations between cold or flu with fever and eight birth defects
We observed statistically significant associations between maternal report of cold or flu with fever during early pregnancy and offspring with gastroschisis and colonic atresia/stenosis that, to the best of our knowledge, have not been reported previously.
We also observed statistically significant associations between exposure to a cold or flu with fever during early pregnancy and six birth defects (anencephaly, spina bifida, encephalocele, cleft lip with or without cleft palate, limb reduction defects, and bilateral renal agenesis or renal hypoplasia), that have been reported in previous studies (Dreier et al., 2014; Moretti et al., 2005; Shaw et al., 2002) . In addition, a study by Acs, Ba'nhidy, Puho', and Czeizel (2005) reported associations for maternal fever and limb deficiencies and renal anomalies that were based on small numbers of exposed cases and did not achieve statistical significance.
| No association between cold or flu with fever and 22 birth defects
Twenty-two of the 30 birth defects that we studied were not associated with exposure to maternal fever from a cold or flu in this study, that is, the aORs were not significantly above or significantly below 1.0. Previous studies addressed the possibility of an association between maternal fever and only 4 of these 22 birth defects (hydrocephaly, anorectal atresia, ear defects, and congenital cataracts) as described below. Consistent with our results, two studies reported no statistically significant association between maternal fever during early pregnancy and hydrocephaly (Acs et al., 2005; Stoll, Alembik, Dott, & Roth, 1992) .
In contrast with our results, two studies observed strong and significant associations between maternal fever and anorectal atresia (van Rooij et al., 2010; Wijers et al., 2010) with odds ratios based on only three and five exposed cases, respectively. In comparison, our study had 56 exposed cases of anorectal atresia and we observed no statistically significant association between maternal fever from a cold or flu and this birth defect.
Only two previous studies, based on the Hungarian Case Control Surveillance of Congenital Anomalies, reported results that were both inconsistent with our findings and had adequate statistical power. These studies observed strong and statistically significant associations between maternal reports of influenza, cold or other respiratory illnesses during early pregnancy and isolated congenital anomalies of the ear, described as "mainly anotia or microtia" (Paput, Czeizel, & Ba'nhidy, 2011) and isolated congenital cataracts (Vogt, Puho', & Czeizel, 2005) . They did not include separate analyses for illnesses associated with or without a fever. Both of these studies and our own study included a large number of exposed cases and therefore low statistical power cannot explain the difference between our findings of no association between maternal cold or flu with fever and these two birth defects and the strong associations observed in these Hungarian studies.
| No associations between cold or flu without fever and 30 birth defects
The detailed questionnaire used by the NBDPS allowed us to make separate assessments of the effects of cold or flu with fever and cold or flu without fever. We observed no significant associations between cold or flu without fever and any of the 30 birth defects in this study. A similar distinction has been made by four of the previous studies (Abe, Honein, & Moore, 2003; Botto et al., 2014; Hashmi, Gallaway, Waller, Langlois, & Hecht, 2010; Lynberg et al., 1994) . Studies of NTDs (Lynberg et al., 1994) , renal anomalies (Abe et al., 2003) and previous NBDPS analyses of cardiac defects (Botto et al., 2014) and previous NBDPS analyses of oral clefts (Hashmi et al., 2010) , observed no associations between cold or flu without illness and the birth defects they studied. This suggests that among mothers exposed to illnesses with fever, it may be fever that contributes to the excess risk of birth defect. However, it is possible that fever serves as a marker for infections that are more severe or due to specific microorganisms.
| Recall bias
Similar to most of the previous case control studies, we measured the occurrence of fever due to cold or flu during pregnancy by maternal interviews conducted after delivery, introducing the possibility that, compared to control mothers, mothers of infants with birth defects may be more likely to recall a "cold or flu" or fever. However, in this analysis, significant associations were present only among mothers who were exposed to fever during the most relevant developmental period of early pregnancy and not for those who were exposed to fevers later during the 3rd or 4th month or pregnancy. Also, there were no statistically significant associations among mothers who were exposed to a cold or flu without a fever during early pregnancy.
In order for this pattern of results to be explained by differential recall bias, it would be necessary for the mothers in our study to have known that: (1) The first 8 weeks of gestation is the developmental period when most birth defects occur (Sadler, 2012) and (2) We postulated that a cold or flu with fever would be more likely to be associated with birth defects than a cold or flu without fever. We believe it is unlikely that the mothers in this study had this knowledge and therefore we think our findings are unlikely to be explained by differential recall bias. Additional evidence against the presence of differential recall of maternal fever is provided by a meta-analysis of the association between maternal fever during early pregnancy and offspring affected by NTDs in which the summary odds ratio for 9 case control studies (OR = 1.93), was observed to be similar to the summary odds ratio for six cohort studies (OR = 1.95) (Moretti et al., 2005) . As differential recall is not possible in cohort studies, the similarity of these results argues against it.
| Multiple statistical tests
We conducted many statistical tests and thus some of the statistically significant associations that we observed may be due to chance. As there is no biologically plausible reason for fever during the 3rd or 4th month of pregnancy to be associated with a reduced risk for duodenal atresia, it is likely that this result is due to chance. Assuming the null hypothesis, that maternal cold or flu with fever during early pregnancy is not associated with any of the 30 birth defects that we studied, by chance alone we would most likely observe approximately one birth defect with a statistically significantly elevated aOR (30*0.05*0.5 = 0.75). However, 8 of the 30 birth defects that we studied had an aOR that was significantly elevated and for 6 of these birth defects (anencephaly, spina bifida, encephalocele, cleft lip with or without cleft palate, limb reduction defects, and bilateral renal agenesis) elevated odds ratios have been reported by previous studies. To the best of our knowledge, the elevated odds ratios that we observed for gastroschisis and colonic atresia have not been reported previously and therefore our findings for these two birth defects should be interpreted more cautiously until they are confirmed by future studies.
| Summary
We observed that report of a cold or flu accompanied by fever during early pregnancy was associated with 8 of the 30 categories of birth defects that we studied. Six of these birth defects have been found to be associated with maternal fever in previous studies and two of them have not been previously studied for this risk factor. We also addressed a gap present in most of the previous studies regarding whether or not illness without fever is associated with birth defects, observing that cold or flu without fever was not associated with any of the 30 categories of birth defects that we studied. This suggests that it may be fever that contributes to the excess risk of birth defect among mothers who have illnesses with fever. However, it is possible that fever serves as a marker for more severe infections.
Future research is needed to determine the role of fever, and whether use of antipyretic medication attenuates the associations we have observed. Women who are planning to become pregnant or have recently become pregnant should take measures to prevent themselves from developing an infection, particularly infections that may lead to a fever. c Use of supplements containing folic acid; optimal (daily intake between 1 month before conception and 1 month after conception), less than optimal (any intake between 1 month before conception and 1 month after conception) and inadequate (intake of folic acid beginning later than 1 month after conception or never).
Waller et al. a Period from 30 days prior to conception to 60 days after conception.
b For some defects the number of controls is less than the number shown here because of adjustments for differences in ascertainment of those birth defects. Percentages calculated after all exclusions.
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